The Impact of Patients' Daily Independent Breathing Training on the Accuracy and Side Effects of Deep Inspiratory Breath-Hold Radiotherapy for Breast Cancer

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Breast cancer DIBH (Deep Inspiration Breath Hold) radiotherapy represents a high-precision treatment approach that substantially minimizes radiation exposure to vital organs such as the heart, thus enhancing protection of the patient's heart, lungs, contralateral breast, and other normal tissues compared to conventional radiotherapy techniques. This method requires meticulous precision, necessitating that patients possess exceptional respiratory control, which is facilitated through specialized equipment. Without such control, patients may encounter issues like missed targets, significant setup errors, and extended treatment durations. In this study, the research team employed portable devices to enable patients to independently perform daily respiratory training exercises. The control group received no such devices; instead, these patients were merely instructed verbally on the importance of improving their breath-holding capabilities. The effectiveness of this intervention was evaluated by comparing the daily setup errors between the two groups. Additionally, the intervention's influence on patient outcomes was assessed by monitoring the toxicity and side effects experienced by the patients.

Eligibility
Participation Requirements
Sex: Female
Healthy Volunteers: f
View:

• Breast Cancer Radiotherapy Patients

• A single breath-hold can last for more than 10 seconds

Locations
Other Locations
China
Zhejiang Hospital
RECRUITING
Hangzhou
Contact Information
Primary
Jianjun Lai
385806945@qq.com
+8615924193343
Time Frame
Start Date: 2024-06-01
Estimated Completion Date: 2026-07-15
Participants
Target number of participants: 80
Treatments
Experimental: Visualized Self-Training
No_intervention: No-Visualized Self-Training
Related Therapeutic Areas
Sponsors
Leads: Jianjun Lai

This content was sourced from clinicaltrials.gov